Menu Close

Impact of Substandard and Falsified Antimalarials in Zambia: Application of the SAFARI Model

Citation

Jackson, Kathryn D.; Higgins, Colleen R.; Laing, Sarah K.; Mwila, Chiluba; Kobayashi, Tamaki; Ippolito, Matthew M.; Sylvia, Sean; & Ozawa, Sachiko (2020). Impact of Substandard and Falsified Antimalarials in Zambia: Application of the SAFARI Model. BMC Public Health, 20(1), 1083. PMCID: PMC7350731

Abstract

BACKGROUND: Many countries are striving to become malaria-free, but global reduction in case estimates has stagnated in recent years. Substandard and falsified medicines may contribute to this lack of progress. Zambia aims to eliminate their annual burden of 1.2 million pediatric malaria cases and 2500 child deaths due to malaria. We examined the health and economic impact of poor-quality antimalarials in Zambia.

URL

http://dx.doi.org/10.1186/s12889-020-08852-w

Reference Type

Journal Article

Journal Title

BMC Public Health

Author(s)

Jackson, Kathryn D.
Higgins, Colleen R.
Laing, Sarah K.
Mwila, Chiluba
Kobayashi, Tamaki
Ippolito, Matthew M.
Sylvia, Sean
Ozawa, Sachiko

Year Published

2020

Volume Number

20

Issue Number

1

Pages

1083

PMCID

PMC7350731

Reference ID

12792